183 related articles for article (PubMed ID: 9652605)
1. Insulin-sensitising agents in polycystic-ovary syndrome.
Sattar N; Hopkinson ZE; Greer IA
Lancet; 1998 Jan; 351(9099):305-7. PubMed ID: 9652605
[No Abstract] [Full Text] [Related]
2. Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
Kuscu NK; Koyuncu FM
Medscape Womens Health; 2002; 7(5):3. PubMed ID: 12466732
[TBL] [Abstract][Full Text] [Related]
3. The polycystic ovary syndrome: treatment with insulin sensitizing agents.
Iuorno MJ; Nestler JE
Diabetes Obes Metab; 1999 May; 1(3):127-36. PubMed ID: 11220291
[No Abstract] [Full Text] [Related]
4. Insulin sensitizers for polycystic ovary syndrome.
Baillargeon JP; Iuorno MJ; Nestler JE
Clin Obstet Gynecol; 2003 Jun; 46(2):325-40. PubMed ID: 12808383
[No Abstract] [Full Text] [Related]
5. Treatment of hyperinsulinaemia in polycystic ovary syndrome?
van Montfrans JM; van Hooff MH; Hompes PG; Lambalk CB
Hum Reprod; 1998 Jan; 13(1):5-6. PubMed ID: 9512218
[No Abstract] [Full Text] [Related]
6. Attenuation of hyperinsulinemia in polycystic ovary syndrome: what are the options?
Ehrmann DA
J Endocrinol Invest; 1998 Oct; 21(9):632-5. PubMed ID: 9856419
[No Abstract] [Full Text] [Related]
7. Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.
Practice Committee of American Society for Reproductive Medicine
Fertil Steril; 2008 Nov; 90(5 Suppl):S69-73. PubMed ID: 19007650
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of PCOS without IVF: weight loss, insulin-sensitizing agents].
Pugeat M
J Gynecol Obstet Biol Reprod (Paris); 2003; 32(3 Pt 2):S25-9. PubMed ID: 12773915
[No Abstract] [Full Text] [Related]
9. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.
Nestler JE
Semin Reprod Endocrinol; 1997 May; 15(2):111-22. PubMed ID: 9165656
[TBL] [Abstract][Full Text] [Related]
10. [Troglitazone for treatment of polycystic ovary syndrome].
Sanaka M; Iwamoto Y
Nihon Rinsho; 2000 Feb; 58(2):465-70. PubMed ID: 10707578
[TBL] [Abstract][Full Text] [Related]
11. [Polycystic ovary syndrome: treatment with insulin-sensitizing agents].
Laboureau-Soares Barbosa S; Rodien P; Rohmer V
Ann Endocrinol (Paris); 2002 Feb; 63(1):31-5. PubMed ID: 11937980
[TBL] [Abstract][Full Text] [Related]
12. Polycystic ovary syndrome.
Ehrmann DA
N Engl J Med; 2005 Mar; 352(12):1223-36. PubMed ID: 15788499
[No Abstract] [Full Text] [Related]
13. Insulin-sensitizing agents in women with polycystic ovary syndrome.
Pasquali R; Gambineri A
Fertil Steril; 2006 Jul; 86 Suppl 1():S28-9. PubMed ID: 16798283
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone use in polycystic ovary syndrome.
Landman RE; Jacobs TP
J Clin Endocrinol Metab; 2001 Oct; 86(10):5090-1. PubMed ID: 11600596
[No Abstract] [Full Text] [Related]
15. The management of insulin resistance in polycystic ovary syndrome.
Teede HJ; Hutchison SK; Zoungas S
Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
[TBL] [Abstract][Full Text] [Related]
16. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
Lord JM; Flight IH; Norman RJ
Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
[TBL] [Abstract][Full Text] [Related]
17. Thiazolidinediones for treatment of polycystic ovary syndrome.
Stout DL; Fugate SE
Pharmacotherapy; 2005 Feb; 25(2):244-52. PubMed ID: 15767238
[TBL] [Abstract][Full Text] [Related]
18. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
Svendsen PF; Nilas L; Nørgaard K; Madsbad S
Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
[TBL] [Abstract][Full Text] [Related]
19. Use of insulin sensitizing agents in the treatment of polycystic ovary syndrome.
Practice Committee of the American Society for Reproductive Medicine
Fertil Steril; 2006 Nov; 86(5 Suppl 1):S221-3. PubMed ID: 17055827
[No Abstract] [Full Text] [Related]
20. [Metformin for the treatment of polycystic ovary syndrome].
Pekhlivanov B; Mitkov M
Akush Ginekol (Sofiia); 2005; 44(4):37-41. PubMed ID: 16028378
[No Abstract] [Full Text] [Related]
[Next] [New Search]
